BioWorld

Dec. 11, 2009

View Archived Issues

Cytokinetics Is All Muscle: Ends Cancer Deal with GSK

A year after GlaxoSmithKline plc backed away from two cancer drugs covered under its collaboration with Cytokinetics Inc., the big pharma handed back rights to the third and final compound as well. (BioWorld Today) Read More

New Trial a Show of Confidence for Oncothyreon Cancer Vaccine

Read More

Plaques, Bad Cholesterol Get Partial Rehab in Alzheimer's

Read More

Despite Concerns, Panel Backs Gilead Inhaled Aztreonam in CF

Read More

Financings Roundup

Read More

Other News To Note

Read More

Clinic Roundup

Read More